If you had backed Premium Brands on the promise of new U.S. plants, capital expansion and acquisition-driven growth, the outcome so far would feel harsh. Holding Premium Brands from the start of the year would have meant a 28.8% loss, including dividends. If that decision sat on your own watchlist, the real question is this: what did the original case around 10.0% revenue growth, 6.1% margins and a 10.8x future P/E fail to allow for?
If the move has made Premium Brands harder to judge, start where the gap is still open and scan 8 high quality undervalued stocks.
The shares cost CA$102 at the start of the period, which left investors weighing two very different stories about Premium Brands.
The bullish view saw new U.S. facilities and programs as the engine for strong expansion, with a Fair Value of CA$113, a notional target based on assumptions like 10.0% annual revenue growth and profit margins rising to 6.1% over three years.
The more cautious angle focused on consumer shifts, tighter regulation and rising labour costs, with a Fair Value of CA$94.73 and a key concern that higher input and compliance expenses would squeeze food margins.
The most concrete update for Premium Brands was record Q2 2026 sales of CA$2,375.7m and record adjusted earnings, which leaned toward the optimistic expansion story. At the same time, net income slipped to CA$17.3m and net margin fell to 0.7%. As a result, the profitability leg of that bullish 6.1% margin thesis remained unproven. Overall, the evidence pointed in both directions.
The useful takeaway is simple. When a growth pitch relies on margin expansion, track net margin and plain net income in each report, not just adjusted metrics or revenue headlines, and test whether they are actually moving toward the numbers in the original case.
Premium Brands now trades at CA$70.61, and the selected Narrative places its Fair Value above that level based on how fully the expanded U.S. footprint and protein lineup might be used over time.
The Narrative leans on existing capacity and a capex cycle that is largely complete. A buyer today would need to believe that major U.S. customers eventually fill that footprint with higher margin protein volumes.
"Key Takeaways Bullish analysts expect Premium Brands Holdings to scale into the largely U.S.-focused capacity it has added since 2022, using the new facilities and growth in protein offerings to support higher organic growth and operating leverage over time. The main thing that has to go right is that large U.S. customers and retailers follow through on deferred sandwich, meat snack and other protein initiatives so that the existing sales pipeline and new capacity convert into sustained volume and earnings growth instead of remaining underutilized."
The price and this Narrative do not agree. → Uncover what this Narrative says Premium Brands is actually worth
The next headline does not have to be where your research begins. Go straight to the companies and see whether a contrarian opportunity could be taking shape.
Those are three of them. See the full list of 7 financially solid companies →
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com